JANE WASMAN, J.D.

Corporate Board Profile

Tech Score: 0/100

RIGEL PHARMACEUTICALS INC

Filing Date	Source Excerpt
2023-04-14	Jane Wasman, age 66, joined us as a director in March 2019. ... Ms. Wasman was selected to serve as a member of the Board in part due to her broad strategic and transactional experience in commercial stage biopharmaceutical companies, as well as her legal and corporate governance background and extensive experience in operational implementation. ... The following directors are currently members of the Audit Committee: Ms. Wasman ... The following directors are currently members of the Corporate Governance, Health Care Compliance Oversight and Nominating Committee: Ms. Wasman (Chair). ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2022: Jane Wasman, J.D. Fees Earned or Paid in Cash ($) 79,854 Stock Awards ($) 50,250 Option Awards ($) 40,926 Total ($) 171,030.

Filing Date

Source Excerpt

2023-04-14

Jane Wasman, age 66, joined us as a director in March 2019. ... Ms. Wasman was selected to serve as a member of the Board in part due to her broad strategic and transactional experience in commercial stage biopharmaceutical companies, as well as her legal and corporate governance background and extensive experience in operational implementation. ... The following directors are currently members of the Audit Committee: Ms. Wasman ... The following directors are currently members of the Corporate Governance, Health Care Compliance Oversight and Nominating Committee: Ms. Wasman (Chair). ... The following table shows the compensation of all non-employee directors of the Company for the fiscal year ended December 31, 2022: Jane Wasman, J.D. Fees Earned or Paid in Cash ($) 79,854 Stock Awards ($) 50,250 Option Awards ($) 40,926 Total ($) 171,030.

Data sourced from SEC filings. Last updated: 2026-03-05